Ryan J. Selhorn - Feb 5, 2025 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Financial Officer
Signature
/s/ Ryan J. Selhorn
Stock symbol
AYTU
Transactions as of
Feb 5, 2025
Transactions value $
$0
Form type
4
Date filed
3/3/2025, 07:22 PM
Previous filing
Nov 13, 2024
Next filing
Oct 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Shares Options Exercise +105 +0.66% 16K Feb 5, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYTU Restricted Stock Units Options Exercise $0 -105 -100% $0.00 0 Feb 5, 2025 Common Shares 105 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units (RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025.